Lucjan Wyrwicz

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Small Cell Lung Cancer

Metastatic Colorectal Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) 20 (13) (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) (2024)
Lucjan Wyrwicz, Cesar A Rodriguez, Pedro Sánchez-Rovira, Sandra Lewis, Darcie Sandschafer, Tevy San
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union. Future oncology (London, England) 20 (13) (2024)
Yelena Y Janjigian, Jaffer A Ajani, Markus Möhler, Lin Shen, Marcelo Garrido, Carlos Gallardo, Lucjan Wyrwicz, Kensei Yamaguchi, James M Cleary, Elena Elimova, Michalis V Karamouzis, Ricardo Bruges, Tomasz Skoczylas, Arinilda Bragagnoli, Tianshi Liu, Mustapha Tehfé, Thomas Zander, Ruben Kowalyszyn, Roberto A Pazo-Cid, Michael Schenker, Kynan Feeny, Rui Wang, Ming Lei, Clara Chen, Raheel Nathani, Kohei Shitara
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Markus Möhler, Hong Xiao, Steven I Blum, Elena Elimova, David Cella, Kohei Shitara, Jaffer A Ajani, Yelena Y Janjigian, Marcelo Garrido, Lin Shen, Kensei Yamaguchi, Tianshu Liu, Michael Schenker, Ruben Kowalyszyn, Arinilda Campos Bragagnoli, Ricardo Bruges, Vincenzo Montesarchio, Roberto A Pazo-Cid, Shannon Hunter, Eric Davenport, Jinyi Wang, Kaoru Kondo, Mingshun Li, Lucjan Wyrwicz
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Keun-Wook Lee, Eric Van Cutsem, Yung-Jue Bang, Charles S Fuchs, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee, Hugo R Castro, Joseph Chao, Zev A Wainberg, Z Alexander Cao, Deepti Aurora-Garg, Julie Kobie, Razvan Cristescu, Pooja Bhagia, Sukrut Shah, Josep Tabernero, Kohei Shitara, Lucjan Wyrwicz
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab±Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)